| Occupational and Environmental Origins of ANCA Vasculitis: Contribution of Data From the National Network for Vigilance and Prevention of Occupational Pathologies (RNV3P) (NCT05416723) | University Hospital, Brest | 2022-07-01 |
| Subclinical Cytomegalovirus Reactivation in Acute ANCA-associated Vasculitis (NCT04916704) | University Hospital Birmingham NHS Foundation Trust | 2022-04-19 |
| Efficacy and Safety of Substitution of Glucocorticoid for BDB-001 Injection in Patients With Anti-neutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis (NCT05197842) | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 2022-02-22 |
| Pediatric ANCA Associated-vasculitis (NCT05383573) | University Hospital, Strasbourg, France | 2022-01-01 |
| the Application of Diffusion Tensor Imaging in the Evaluation of Peripheral Neuropathy in ANCA Associated Vasculitis (NCT04923074) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-07-01 |
| Comparison of the Efficacy of Leflunomide and Azathioprine for the Maintenance Therapy of ANCA Associated Vasculitis (NCT04737343) | Chinese SLE Treatment And Research Group | 2021-06-30 |
| Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator (NCT05716334) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2021-06-15 |
| Patients With Co-occurrence of ANCA Vasculitis and Sjögren Syndrome (NCT04895878) | University Hospital, Montpellier | 2021-05-01 |
| PRediction Of DIverse Glucocorticoids toxIcity OUtcomeS (NCT04664465) | University Hospital, Brest | 2021-03-18 |
| Hydroxychloroquine in ANCA Vasculitis Evaluation (NCT04316494) | Guy's and St Thomas' NHS Foundation Trust | 2020-12-17 |
| PRagmatic Analysis of Vitamin D in ANCA-Associated Vasculitis (NCT04280601) | Christian Pagnoux | 2020-08-01 |
| Effect of Tofacitinib in Treating ANCA-associated Vasculitis (NCT04973033) | Shanghai Zhongshan Hospital | 2019-12-01 |
| Tailoring Maintenance Therapy to Cluster of Differentiation 5 Positive (CD5+) Regulatory B Cell Recovery in ANCA Vasculitis (NCT03906227) | University of North Carolina, Chapel Hill | 2019-06-28 |
| Exploring Durable Remission With Rituximab in Antineutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis (NCT03942887) | Leiden University Medical Center | 2019-05-03 |
| Rituximab and Belimumab Combination Therapy in PR3 Vasculitis (NCT03967925) | Rachel Jones | 2019-02-01 |
| Soluble CD95 Ligand Role in the Pathophysiology of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis (NCT03698071) | University Hospital, Bordeaux | 2018-12-14 |
| MICRO-RNAs OF NEUTROPHILS IN RENAL ANTINEUTROPHIL CYTOPLASMIS ANTIBODY (ANCA) -ASSOCIATED VASCULITIS (NCT02954705) | Nantes University Hospital | 2017-08-28 |
| A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis (NCT02994927) | Amgen | 2017-03-15 |
| Residual Anti-pneumococcal Immunity After Pneumococcal Immunization in ANCA-associated Vasculitis (NCT02463539) | Assistance Publique - Hôpitaux de Paris | 2015-09-01 |
| Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated Vasculitis (NCT02463578) | Assistance Publique - Hôpitaux de Paris | 2015-06-01 |
| Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) (NCT02108860) | University of South Florida | 2015-04-25 |
| Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis (NCT02222155) | Amgen | 2015-02-04 |
| Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis (NCT02257866) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2014-09-29 |
| Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary Vasculitis (NCT02126098) | Peking Union Medical College Hospital | 2014-05-01 |
| Defining Immune Tolerance in ANCA-associated Vasculitis (AAV) (NCT01934504) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-12-01 |
| CMV Modulation of the Immune System in ANCA-associated Vasculitis (NCT01633476) | Professor Lorraine Harper | 2013-07-01 |
| Abatacept in ANCA Associated Vasculitis (NCT00482066) | Imperial College London | 2007-11-01 |
| Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis (NCT00293072) | Cambridge University Hospitals NHS Foundation Trust | 2002-03-01 |